Renal Complications and Their Prognosis in Korean Patients with Middle East Respiratory Syndrome-Coronavirus from the Central MERS-CoV Designated Hospital

Journal of Korean Medical Science

Volumn 30, Issue 12, 2015, Pages 1807-1814

  Cha, Ran Hui ^a   Joh, Joon Sung ^b   Jeong, Ina ^b   Lee, Ji Yeon ^b   Shin, Hyoung Shik ^c   Kim, Gayeon ^c   Kim, Yeonjae ^c  

^a Division of Nephrology

^b Department of Internal Medicine

^c National Medical Center   (South Korea)

Author keywords

East Respiratory Syndrome Coronavirus; Middle; Prognosis; Renal Complication

Indexed keywords

CREATININE;

ACUTE KIDNEY INJURY; ADULT; AGED; BLOOD; COMPLICATION; CORONAVIRUS INFECTION; EPIDEMIOLOGY; FEMALE; GLOMERULUS FILTRATION RATE; HEMATURIA; HOSPITAL; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDY; RISK FACTOR; SOUTH KOREA;

ACUTE KIDNEY INJURY; ADULT; AGED; CORONAVIRUS INFECTIONS; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HEMATURIA; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 85016079291     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2015.30.12.1807     Document Type: Article

References (22)

1. 1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367: 1814-20.
2. 2. Memish ZA, Zumla AI, Al-Hakeem RF, Al-Rabeeah AA, Stephens GM. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 2013; 368: 2487-94.
3. 3. Guery B, Poissy J, el Mansouf L, Séjourné C, Ettahar N, Lemaire X, Vuo-tto F, Goffard A, Behillil S, Enouf V, et al.; MERS-CoV study group. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet 2013; 381: 2265-72.
4. 4. Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, Alabdullatif ZN, Assad M, Almulhim A, Makhdoom H, et al.; KSA MERS-CoV Investigation Team. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 2013; 369: 407-16.
5. 5. Raj VS, Mou H, Smits SL, Dekkers DH, Müller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 2013; 495: 251-4.
6. 6. Hong WJ, Petell JK, Swank D, Sanford J, Hixson DC, Doyle D. Expression of dipeptidyl peptidase IV in rat tissues is mainly regulated at the mRNA levels. Exp Cell Res 1989; 182: 256-66.
7. 7. Lu G, Hu Y, Wang Q, Qi J, Gao F, Li Y, Zhang Y, Zhang W, Yuan Y, Bao J, et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 2013; 500: 227-31.
8. 8. Kenny AJ, Booth AG, George SG, Ingram J, Kershaw D, Wood EJ, Young AR. Dipeptidyl peptidase IV, a kidney brush-border serine peptidase. Biochem J 1976; 157: 169-82.
9. 9. Lambeir AM, Durinx C, Scharpé S, De Meester I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 2003; 40: 209-94.
10. 10. Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, Hawa H, Alothman A, Khaldi A, Al Raiy B. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 2014; 160: 389-97.
11. 11. Drosten C, Seilmaier M, Corman VM, Hartmann W, Scheible G, Sack S, Guggemos W, Kallies R, Muth D, Junglen S, et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 2013; 13: 745-51.
12. 12. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, AlBarrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013; 13: 752-61.
13. 13. Chu KH, Tsang WK, Tang CS, Lam MF, Lai FM, To KF, Fung KS, Tang HL, Yan WW, Chan HW, et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int 2005; 67: 698705.
14. 14. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, et al.; HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003; 361: 176772.
15. 15. Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, Wang H, Shen H, Qiu L, Li Z, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 2004; 203: 622-30.
16. 16. Lai KN, Tsang KW, Seto WH, Ooi CG. Clinical, Laboratory, and Radiologic Manifestation of SARS. Curr Infect Dis Rep 2004; 6: 213-9.
17. 17. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003; 426: 450-4.
18. 18. Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expres sion profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett 2002; 532: 107-10.
19. 19. National Library of Medicine (US), National Center for Biotechnology Information. Dipeptidyl-peptidase 4 (DPP4). UGID:197782, UniGene Hs. 368912 Homo sapiens (human) DPP4. Available at http://www. ncbi.nlm.nih.gov/UniGene [accessed on 15 September 2015].
20. 20. Hocke AC, Becher A, Knepper J, Peter A, Holland G, Tönnies M, Bauer TT, Schneider P, Neudecker J, Muth D, et al. Emerging human middle east respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs. Am J Respir Crit Care Med 2013; 188: 882-6.
21. 21. Chan JF, Chan KH, Choi GK, To KK, Tse H, Cai JP, Yeung ML, Cheng VC, Chen H, Che XY, et al. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis 2013; 207: 1743-52.
22. 22. Poissy J, Goffard A, Parmentier-Decrucq E, Favory R, Kauv M, Kipnis E, Mathieu D, van der Werf S, Guery B; MERS-CoV Biology Group. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. J Clin Virol 2014; 61: 275-8.